Investing

Top Analyst Upgrades and Downgrades: CONSOL Energy, Kroger, 3M, NVIDIA, Qualcomm, Xilinx and More

Accuray Inc. (NASDAQ: ARAY) was downgraded to Neutral from Overweight with a $6 price target (versus a $5.15 close) at JPMorgan.

Akamai Technologies Inc. (NASDAQ: AKAM) was raised to Outperform from Perform with an $80 price target (versus a $65.14 close) at Oppenheimer.

Crestwood Midstream Partners L.P. (NYSE: CEQP) was started with a Buy rating and assigned a $30 price target (versus a $23.50 close) at Goldman Sachs. The company has one of the 10% or so payout rates on a distribution yield equivalent, but it also has just a $21.29 consensus price target.

Kaiser Aluminum Corp. (NASDAQ: KALU) was downgraded to Neutral from Outperform at Macquarie.

Lazard Ltd. (NYSE: LAZ) was started as Underperform and given a $40 price objective (versus a $42.40 close) at Merrill Lynch. The firm sees a challenging near-term outlook and earnings in 2017 at 10% below consensus.

Marathon Oil Corp. (NYSE: MRO) was raised to Buy from Hold at Argus.

Moelis & Co. (NYSE: MC) was started with a Buy rating and assigned a $37 price objective (versus a $30.15 close) at Merrill Lynch.

NextEra Energy Partners L.P. (NYSE: NEP) was reinstated with a Buy rating and assigned a $27 price objective (versus a $24.96 close) at Merrill Lynch.

Omega Protein Corp. (NYSE: OME) was started with a Buy rating and assigned a $29 price target (versus $a 25.65 close) at Deutsche Bank.

OneMain Holdings Inc. (NYSE: OMF) was started as Buy and assigned a $29 price target (versus a $21.57 close) at Deutsche Bank.

PetroChina Co. Ltd. (NYSE: PTR) was raised to Neutral from Underperform at Credit Suisse.

Red Robin Gourmet Burgers Inc. (NASDAQ: RRGB) was raised to Neutral from Underperform and the price objective was raised to $54 from $45 at Merrill Lynch. The call is after a new chief financial officer announcement.

Sage Therapeutics Inc. (NASDAQ: SAGE) was raised to Strong Buy from Outperform with an $84 price target (versus a $48.07 close) at Raymond James.

Sarepta Therapeutics Inc. (NASDAQ: SRPT) was maintained as Hold at Jefferies, but the target was cut to $32 from $46 (versus a $31.82 close). The call was based on stronger payer pushback and slower uptake and launch for Exondys 51.

Universal Health Services Inc. (NYSE: UHS) was downgraded to Market Perform from Outperform at Raymond James.

Was Citigroup’s big upside for Apple really all that big?

Deutsche Bank has its top networking stock picks for 2017.

Merrill Lynch has raised its targets on steel stocks again.

Tuesday’s top analyst upgrades and downgrades included Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld, NovoCure and over a dozen more.